Skip to content
HowShorted

SELLAS Life Sciences Group, Inc. short interest in 2021

In 2021, SELLAS Life Sciences Group, Inc.'s disclosed short interest ran from 6.72% of shares outstanding on 15 Jan 2021 to 4.89% on 31 Dec 2021, a change of -1.83 percentage points. The year's high was 10.15% on 12 Feb 2021 and its low 4.09% on 15 Nov 2021, averaging 6.24% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 6.82 days on 15 Oct 2021. Full history: SELLAS Life Sciences Group, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for SELLAS Life Sciences Group, Inc. in 2021

2021 in figures

Start of year
6.72% (15 Jan 2021)
End of year
4.89% (31 Dec 2021)
Change
-1.83 pp
High
10.15% (12 Feb 2021)
Low
4.09% (15 Nov 2021)
Average
6.24%
Highest days to cover
6.82 (15 Oct 2021)
SEC filings marked
9

Every report in 2021

SELLAS Life Sciences Group, Inc. short interest in 2021
SettlementShort interestDays to coverFilings since previous
15 Jan 20216.72%1.00results (8-K)
29 Jan 20219.65%1.45
12 Feb 202110.15%1.00
26 Feb 20218.51%1.07
15 Mar 20219.01%1.04
31 Mar 20215.19%1.3510-K filed, results (8-K)
15 Apr 20216.23%1.28
30 Apr 20215.97%3.42
14 May 20216.04%5.2910-Q filed, results (8-K)
28 May 20215.13%1.99
15 Jun 20214.57%1.09
30 Jun 20215.81%1.00
15 Jul 20217.51%1.70
30 Jul 20217.80%4.27
13 Aug 20217.41%4.3810-Q filed, results (8-K)
31 Aug 20215.68%3.42
15 Sep 20214.87%3.88
30 Sep 20215.22%4.49
15 Oct 20215.44%6.82
29 Oct 20214.24%6.50
15 Nov 20214.09%2.5210-Q filed, results (8-K)
30 Nov 20214.57%5.09
15 Dec 20215.01%6.48
31 Dec 20214.89%4.37

See also: SELLAS Life Sciences Group, Inc.'s full history · most shorted US stocks of 2021 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.